Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Sun Exposure Makes No Discrimination Based on Vitamin D Status and Vdr-Foki Polymorphisms for Non-Melanoma Skin Cancers Risk in Iranian Subjects: A Case-Control Study Publisher Pubmed



Rezaiian F1 ; Davoodi SH1 ; Nikooyeh B2 ; Ehsani AH3 ; Kalayi A2 ; Shariatzadeh N2 ; Zahedirad M2 ; Neyestani TR1
Authors

Source: Asian Pacific Journal of Cancer Prevention Published:2022


Abstract

Background and Objective: Sunlight exposure, the main source of endogenous vitamin D synthesis, may increase the risk of non-melanoma skin cancers (NMSC) development. Vitamin D receptor (VDR) polymorphisms are associated with various malignancies. This study aimed to examine the associations between vitamin D status and VDR FokI polymorphisms in Iranian subjects with NMSC. Materials and Methods: This case-control study included 73 diagnosed cases of NMSC and 72 healthy controls from dermatology clinics at Razi Hospital, Tehran, Iran. A questionnaire was used to assess sunlight exposure. The extracted DNA from whole blood samples was genotyped and serum concentrations of 25-hydroxycalciferol (25(OH)D)) and intact parathyroid hormone (iPTH) were measured. Results: We found a significant higher duration of cumulative sunlight exposure in cases compared with controls (p<0.001). However, 25(OH)D and iPTH concentrations were not significantly different between cases and controls (30±15 vs. 29±15 ng/ mL, p=0.78 and 46.0±20 vs. 40.5±23 pg/mL, p=0.14, respectively). We did not observe any significant increased risk of NMSC due to f allele, as compared with FF (OR =2.33, 95% CI 0.81-6.75, p=0.12). Conclusion: Though sunlight exposure was associated with increased NMSC risk, there were no significant associations between vitamin D status or VDR FokI polymorphisms with NMSC development in our subjects. © This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License.
Other Related Docs
9. Vitamin D Receptor Gene Polymorphisms and the Risk of Metabolic Syndrome (Mets): A Meta-Analysis, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)